Runners are encouraged to strip down to their underwear or don creative costumes to raise awareness and money for NF with ...
RENO, Nev. (KOLO) - Saturday, Feb. 22 hundreds of people in Reno will take to the streets in just their undies during Cupid’s Undie Run. The event raises awareness of neurofibromatosis (NF), a genetic ...
Snagging its second U.S. FDA approval since being spun out of Pfizer Inc. in 2017, Springworks Therapeutics Inc. is aiming to position Gomekli (mirdametinib), cleared for neurofibromatosis type ...
Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that are not amenable ...
The FDA on Tuesday signed off on SpringWorks Therapeutics’ mirdametinib—now to carry the brand name Gomekli—for the treatment ...
2d
GlobalData on MSNFDA approves Gomekli as first neurofibromatosis drug for adultsThe US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...
Adam Pearson used his neurofibromatosis struggles to succeed in acting and advocacy, inspiring others to accept differences ...
Stamford-based SpringWorks Therapeutics, a commercial-stage biotech company developing treatments for rare diseases and ...
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Children's Tumor Foundation raises awareness and funds research to fight neurofibromatosis and schwannomatosis (NF), a rare genetic condition that causes tumors to grow on nerves throughout the body.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results